☆ 4.6 Review

Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Cell Biology

Salivary carcinosarcoma: insight into multistep pathogenesis indicates uniform origin as sarcomatoid variant of carcinoma ex pleomorphic adenoma with frequent heterologous elements

Stephan Ihrler et al.

Summary: The formal pathogenesis of salivary carcinosarcoma (SCS) is clarified in this study, showing that it almost always develops from pleomorphic adenoma (PA) and follows a multistep adenoma-carcinoma-sarcoma sequence. This finding suggests that SCS is a rare and unique variant of carcinoma ex PA with secondary sarcomatous overgrowth.

HISTOPATHOLOGY (2023)

Add to Collection

Review Pharmacology & Pharmacy

RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives

Alfredo Addeo et al.

Summary: Precision oncology informed by genomic information has made significant progress in the last decade. Multiple targetable genomic alterations have been identified in various cancer types, including a 2% occurrence of RET alterations. The rapid development and approval of selective RET inhibitors have opened up new possibilities for RET precision oncology.

PHARMACOLOGY & THERAPEUTICS (2023)

Add to Collection

Review Oncology

Targeting HER2 in metastatic gastroesophageal adenocarcinomas: What is new?

Clelia Coutzac et al.

Summary: Gastric and esophageal adenocarcinomas are biologically heterogeneous diseases. The discovery of HER2 overexpression has led to the development of targeted therapies and the combination with immune checkpoint inhibitors has shown promising results.

BULLETIN DU CANCER (2023)

Add to Collection

Article Oncology

Systemic and Targeted Therapies in Adenoid Cystic Carcinoma

Alec J. Kacew et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2023)

Add to Collection

Article Pathology

Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment

Sajjad Gerdabi et al.

Summary: The expression of PD-1 and PD-L1 in salivary gland tumors varies and is associated with the clinicopathological characteristics of the patients. The simultaneous expression of PD-1 and PD-L1 suggests the therapeutic potential of anti-PD-1 and anti-PD-L1 combinational immunotherapy for salivary gland tumors.

HEAD & NECK PATHOLOGY (2023)

Add to Collection

Article Pathology

Clinicopathological and molecular study of 10 salivary gland clear cell carcinomas, with emphasis on rare cases with high grade transformation and occurring in uncommon sites

Lanlan Xuan et al.

Summary: This study identified the features that allow better recognition of the clinicopathological and molecular characteristics and the prognosis of CCC, focusing on high-grade transformation (HGT) in this tumor and cases arising in uncommon sites. The results showed that combining morphology-based IHC and molecular detection provided reliable evidence for diagnosing CCC and differentiating it from other tumors, avoiding potential misdiagnosis and inappropriate therapy.

DIAGNOSTIC PATHOLOGY (2022)

Add to Collection

Article Oncology

Prognostic factors in acinic cell carcinoma of the head and neck: The Amsterdam experience

Stijn van Weert et al.

Summary: The aim of this study was to analyze prognosticators in acinic cell carcinoma (AciCC) in two head and neck referral centers in Amsterdam. The majority of AciCC cases were T1-T2, and the most affected organ was the parotid gland. The study found that AciCC of the head and neck, excluding high-grade transformation, had an excellent prognosis and acceptable long-term results.

ORAL ONCOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer

Sarina K. K. Mueller et al.

Summary: Surgical resection is the preferred treatment for salivary gland cancer. For inoperable and metastatic disease, various systemic therapies are available. However, there is a need for more research and molecular analysis to improve treatment outcomes.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Pathology

Heterotopic SMARCB1-deficient high-grade transformed/dedifferentiated acinic cell carcinoma and sine-qua-non radiology- pathology with TNM challenge

Ellie Maghami et al.

Summary: This article reports a rare case of heterotopic dedifferentiated acinic cell carcinoma (AciCC) and highlights the importance of meticulous pathological investigation and multidisciplinary decision-making process. Definitive surgery and follow-up are necessary for this rare condition.

ANNALS OF DIAGNOSTIC PATHOLOGY (2022)

Add to Collection

Review Oncology

The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives

Giorgio Patelli et al.

Summary: HER2 alterations are potential targets for targeted treatments in metastatic urothelial/bladder cancer (mUC). Clinical trials have shown that dual HER2 blockade and certain ADCs have demonstrated activity in mUC with ERBB2 amplification. However, HER2-targeted monotherapy and combination treatments with chemotherapy have shown limited benefits for ERBB2 amplification, and HER2-targeted monotherapy for ERBB2 mutations is still at an early stage of study.

CANCER TREATMENT REVIEWS (2022)

Add to Collection

Review Pharmacology & Pharmacy

An overview of the preclinical discovery and development of trastuzumab deruxtecan: a novel gastric cancer therapeutic

James Kalmuk et al.

Summary: Gastric cancer is a common disease worldwide with poor prognosis. Overexpression of HER2 in tumors is associated with poor outcomes. Despite the efficacy of trastuzumab in HER2-positive gastric cancer, subsequent trials of HER2-targeted therapy have been disappointing. However, the antibody-drug conjugate trastuzumab deruxtecan has shown survival benefits in gastric cancer patients who progressed on trastuzumab.

EXPERT OPINION ON DRUG DISCOVERY (2022)

Add to Collection

Article Oncology

Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial

Akihiro Ohba et al.

Summary: Trastuzumab deruxtecan (DS-8201) has shown efficacy in HER2-positive breast and gastric cancers, and there is evidence to suggest its potential activity in HER2-positive biliary tract cancers. This article describes the rationale and design of the phase II HERB trial, which aims to evaluate the efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing unresectable or recurrent biliary tract cancers.

FUTURE ONCOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Pretherapeutic Predictive Factors for Histological High-Grade Parotid Gland Carcinoma

Takuya Mikoshiba et al.

Summary: Through a retrospective study of 111 patients with parotid gland carcinoma, this research found that high T and N classification, as well as elevated CRP, are important predictors of PGC histological grade. These findings are valuable for guiding treatment planning and obtaining necessary consent from patients before treatment.

LARYNGOSCOPE (2022)

Add to Collection

Article Virology

Analysis of Human Papillomavirus (HPV) and Polyomaviruses (HPyVs) in Adenoid Cystic Carcinoma (AdCC) of the Head and Neck Region Reveals Three HPV-Positive Cases with Adenoid Cystic-like Features

Mark Zupancic et al.

Summary: HPV and HPyV do not play a major role in AdCC. HMSC may be considered as a basaloid variant of squamous cell carcinoma, but further characterization is needed.

VIRUSES-BASEL (2022)

Add to Collection

Review Oncology

Diagnosis and Treatment of ERBB2-Positive Metastatic Colorectal Cancer A Review

John H. Strickler et al.

Summary: ERBB2 amplification is present in a small percentage of patients with metastatic colorectal cancer, and targeted therapies may represent a new standard of care for this patient population.

JAMA ONCOLOGY (2022)

Add to Collection

Review Oncology

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2

Maria Eugenia Olmedo et al.

Summary: The discovery of gene mutations in EGFR and rearrangements in ALK in 2004 marked the beginning of a targeted therapy era for advanced non-small cell lung cancer. In addition to EGFR and ALK, other gene alterations such as ROS1 have been identified as potential therapeutic targets for a small subgroup of patients.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Demography, patterns of care, and survival outcomes in patients with salivary duct carcinoma: an individual patient data analysis of 857 patients

Prashanth Giridhar et al.

Summary: Salivary duct carcinoma (SDC) is a rare and aggressive malignancy. The optimal treatment protocols are debated. The study found that surgery and adjuvant radiation have positive effects on the survival of patients with SDC, and AR expression is associated with survival prognosis.

FUTURE SCIENCE OA (2022)

Add to Collection

Review Oncology

Advances in the Treatment of Mucoepidermoid Carcinoma

Srikar Sama et al.

Summary: Mucoepidermoid carcinoma (MEC) is a common subtype of salivary neoplasms, but its low incidence poses challenges in clinical trials and treatment guideline development. Surgery is the most common approach for resectable tumors, but other options such as chemotherapy, radiotherapy, and immunotherapy are being investigated. Standardized treatment protocols and assessment of chromosomal and genetic abnormalities are necessary for effective management of MEC. Biomarker-driven research can greatly improve outcomes, especially in advanced cases.

WORLD JOURNAL OF ONCOLOGY (2022)

Add to Collection

Article

Heterogeneity of Genetic Landscapes in Salivary Gland Tumors and Their Critical Roles in The Current Management

Anam yousaf et al.

Medeniyet medical journal (2022)

Add to Collection

Article Oncology

High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity

Eva Karamitopoulou et al.

Summary: This study links tumor mutational burden (TMB) levels with immune pathway activation and intratumoral immune responses in pancreatic adenocarcinoma (PDAC). The results show that TMB-high cases frequently belong to specific PDAC subsets with prolonged survival and display strong anti-tumor immune responses.

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Review Oncology

Approaches to the Management of Metastatic Adenoid Cystic Carcinoma

Rex H. Lee et al.

Summary: Patients with adenoid cystic carcinoma often experience late distant metastasis, especially to the lungs, years after treatment. The optimal treatment for metastatic ACC is still unclear and the clinical benefit is modest. This article outlines management approaches for metastatic ACC, including commonly used systemic treatment regimens, local control methods, and emerging molecular targets.

CANCERS (2022)

Add to Collection

Review Oncology

New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung Cancer

Nicolas Girard

Summary: Osimertinib is the standard-of-care for EGFR-mutant NSCLC, but progression after treatment is inevitable. Current treatment options beyond progression mainly involve platinum doublet chemotherapy. However, with better understanding of resistance mechanisms, targeted agents can be considered. Proposed strategies for current clinical practice include continuation of osimertinib, tissue rebiopsy and liquid biopsy to evaluate resistance mechanisms, assessment for enrollment in clinical trials or expanded access programs, and use of platinum-based chemotherapy with antiangiogenic agents if no resistance mechanism is identified.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Distinct histone H3 modification profiles correlate with aggressive characteristics of salivary gland neoplasms

Aroonwan Lam-Ubol et al.

Summary: This study investigated the degree of histone H3 modifications in salivary gland neoplasms and their associations with tumor pathologic characteristics and proliferation. The results showed that different types of salivary gland tumors acquire distinct patterns of histone H3 modification, which impact prognostically relevant cancer phenotypes.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Oncology

Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients

Gerben Lassche et al.

Summary: This research aimed to assess the prevalence of actionable aberrations in salivary gland cancer (SGC) and identified several new gene fusions. Targets for genetically matched therapies were found in different SGC subtypes. This highlights the potential importance of molecular diagnostics in selecting systemic treatment for SGC.

CANCERS (2022)

Add to Collection

Review Health Care Sciences & Services

NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series

Giovanni Maria Iannantuono et al.

Summary: The approval of larotrectinib and entrectinib for cancer patients with NTRK gene fusion marks a milestone in the era of histology-agnostic drugs. With the increasing availability of next-generation sequencing assays in clinical settings, TRK inhibitors may have potential benefits for patients with tumor types not represented in clinical trials.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Review Immunology

Predictive biomarkers of colon cancer immunotherapy: Present and future

Wanting Hou et al.

Summary: Immunotherapy has revolutionized colon cancer treatment, especially for patients with high microsatellite instability. In addition to microsatellite instability, other biomarkers have been proposed to be correlated with patient survival and immunotherapy efficacy, highlighting the importance of further search for predictive biomarkers in colon cancer immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer

Zhengyang Yang et al.

Summary: Immunotherapies, especially PD-1/PD-L1 inhibitors, have revolutionized cancer treatment. Their effectiveness in CRC depends on the mutation pattern, and combining them with other treatments has been proposed for better therapeutic effect. Neoadjuvant therapy, including chemotherapy and radiotherapy, can improve clinical symptoms and life quality. Incorporating immunotherapy into neoadjuvant therapy may shift the treatment strategy for some CRC patients.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma

Daisuke Kawakita et al.

Summary: This retrospective study analyzed the treatment outcomes of 323 patients with locally advanced, recurrent, or metastatic salivary duct carcinoma (SDC). The results showed that patients treated with HER2-targeted therapy and androgen deprivation therapy (ADT) had longer overall survival. HER2-targeted therapy can be recommended as first-line treatment for HER2-positive/AR-positive SDC.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

Add to Collection

Review Oncology

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer

Carlos Alexander Huertas-Caro et al.

Summary: Triple-negative breast cancer (TNBC) is more common in young non-Hispanic black and Hispanic/Latina women, and is considered the most aggressive subtype of breast cancer. Immune infiltrate is associated with long-term survival, lower risk of death and recurrence, and response to chemotherapy in TNBC. Higher levels of tumor-infiltrating lymphocytes (TILs) in TNBC patients are associated with longer overall survival and disease-free survival times.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report

Matthew S. Ernst et al.

Summary: NTRK gene fusions are rare oncogenic driver mutations that can be found in various tumors. In secretory carcinoma, ETV6-NTRK3 gene fusion is commonly present and can be targeted for treatment. In this case, a patient with recurrent, metastatic secretory carcinoma achieved a durable response of 49 months with entrectinib. Entrectinib is well-tolerated and has the potential for long-lasting responses.

CURRENT ONCOLOGY (2022)

Add to Collection

Article Pathology

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms

Ozgur Mete et al.

Summary: This review article provides a brief overview of the new WHO classification for head and neck neuroendocrine neoplasms. It discusses the spectrum of these neoplasms, diagnostic criteria, and offers insights into the role of biomarkers and molecular immunohistochemistry in accurate diagnosis. The article emphasizes the importance of morphology and immunohistochemical findings in the classification and diagnosis of neuroendocrine neoplasms.

HEAD & NECK PATHOLOGY (2022)

Add to Collection

Article Otorhinolaryngology

Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL), part II: Management of recurrent pleomorphic adenoma of the parotid gland

O. Malard et al.

Summary: The guidelines presented by SFORL for the management of recurrent pleomorphic adenoma (RPA) of the parotid gland recommend complete resection under neuromonitoring, use of MRI before surgery, and consideration of radiotherapy in certain cases such as multi-recurrent RPA or non-operable RPA.

EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2021)

Add to Collection

Article Medicine, Research & Experimental

Prognostic Value of Tumor Proportion Score in Salivary Gland Carcinoma

Fumihiko Sato et al.

Summary: Limited information is available about the role of PD-L1 expression and CD8(+)TIL density in the tumor immune microenvironment of salivary gland carcinoma (SGC) patients. This study aimed to evaluate the association between patient prognosis and PD-L1 expression, CD8(+)TIL density, and other immune-related parameters. The results suggest that TPS may be a useful prognostic biomarker for SGC patients undergoing definitive surgery.

LARYNGOSCOPE (2021)

Add to Collection

Article Oncology

Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system

Naruhiko Morita et al.

Summary: The study introduces the minAmax system as a simple, objective, and highly reproducible grading system useful for prognostic stratification in salivary AdCC. After a central pathology review of AdCC cases, it was found that the minAmax system and van Weert system were independent prognostic tools.

CANCER SCIENCE (2021)

Add to Collection

Article Oncology

The impact of nodal status in major salivary gland carcinoma: A multicenter experience and proposal of a novel N-classification

Davide Lombardi et al.

Summary: Despite differences in oncological behavior, a more reliable N-classification for major salivary glands (MSG) carcinoma is needed. In this retrospective multicenter study of 307 patients, intra-parotid nodes, overall number and largest diameter of nodal metastases were identified as major prognosticators for overall survival. Three novel proposed N-classifications showed better accuracy in overall survival stratification compared to the current TNM staging, suggesting potential for improved prognostic evaluation in MSG carcinoma.

ORAL ONCOLOGY (2021)

Add to Collection

Review Oncology

PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer

Alessandro Rizzo et al.

Summary: ICIs have revolutionized the treatment landscape for several malignancies, but their efficacy in biliary tract cancer remains controversial. The lack of reliable predictive biomarkers presents a significant challenge in identifying responders to immunotherapy in this setting.

CANCERS (2021)

Add to Collection

Review Oncology

Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab

Amirali Karimi et al.

Summary: Ipilimumab, a monoclonal anti-CTLA4 antibody, has shown promising results in treating various cancers, particularly melanoma. However, its use may lead to autoimmune complications, highlighting the importance of recognizing and managing adverse events. Despite some non-melanoma cancers not having FDA approval yet, Ipilimumab has demonstrated effectiveness in this group as well.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Pathology

High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance

Alena Skalova et al.

Summary: High-grade transformation in salivary gland carcinomas consists of traditional low-grade components intermingled with areas of high-grade morphology, with higher Ki-67 labeling index and potential genetic alterations like p53 inactivation and HER2 overexpression. These tumors are more aggressive than conventional carcinomas, with a higher recurrence rate and poorer prognosis, necessitating thorough sampling to avoid overlooking the high-grade component.

ADVANCES IN ANATOMIC PATHOLOGY (2021)

Add to Collection

Article Pathology

Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors

Marie Csanyi-Bastien et al.

Summary: The study aimed to evaluate the utility of pan-TRK immunohistochemistry in distinguishing secretory carcinoma (SC) from other salivary gland tumors, with nuclear pan-TRK staining showing high specificity for SCs with ETV6-NTRK3 fusion. Pan-TRK staining serves as a strong diagnostic marker to distinguish SC from its mimics and select patients eligible for TRK inhibitor clinical trials.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Add to Collection

Review Pathology

High-grade salivary gland carcinoma with the ETV6-NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high-grade transformation

Satsuki Asai et al.

Summary: This case presents a rare instance of secretory carcinoma with high-grade transformation, with immunohistochemistry and molecular analysis aiding in the diagnosis of SCHG.

PATHOLOGY INTERNATIONAL (2021)

Add to Collection

Article Oncology

Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer

Ajaratu Keshinro et al.

Summary: The study characterized the relationship between TIL, TMB, and genetic alterations in MSS, MSI, or mutant POLE/POLD1 colon cancer. Results showed significant differences in TIL and TMB levels between different phenotypes, which may help explain tumoral immunity and serve as predictors of response to immunotherapy.

JCO PRECISION ONCOLOGY (2021)

Add to Collection

Review Pathology

Primary Parotid Merkel Type Small Cell Neuroendocrine Carcinoma with Oligometastasis to the Brain and Adrenal Gland: Case Report and Review of Literature

Sympascho Young et al.

Summary: Oligometastatic disease is a hypothetical intermediate stage between localized and widespread metastatic cancer, where localized treatment may provide survival benefits. This case describes a patient with rare oligometastatic small cell neuroendocrine carcinoma Merkel type, treated with chemotherapy and radiotherapy, maintaining good functional status and low disease burden.

HEAD & NECK PATHOLOGY (2021)

Add to Collection

Article Cell Biology

Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm

Masato Nakaguro et al.

HISTOPATHOLOGY (2020)

Add to Collection

Article Otorhinolaryngology

Next-generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage-Multicenter experience

Assaf Moore et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

Add to Collection

Article Oncology

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study

Shanu Modi et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Cell Biology

Immunohistochemical Reactivity of Prostate-Specific Markers for Salivary Duct Carcinoma

Nami Takada et al.

PATHOBIOLOGY (2020)

Add to Collection

Review Oncology

Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease

Larissa Di Villeneuve et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Mathematical & Computational Biology

Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden

Jiaqiong Lin et al.

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2020)

Add to Collection

Review Biology

Systemic treatment of advanced or recurrent biliary tract cancer

Wei Zhang et al.

BIOSCIENCE TRENDS (2020)

Add to Collection

Review Pathology

Adenoid Cystic Carcinoma with Transformation to High Grade Carcinomatous and Sarcomatoid Components: A Rare Case Report with Review of Literature

Anupurva Dutta et al.

HEAD & NECK PATHOLOGY (2020)

Add to Collection

Article Pathology

Low Molecular Weight Cytokeratin Immunostaining for Extrafollicular Reticulum Cells is an Effective Means of Separating Salivary Gland Tumor-Associated Lymphoid Proliferation from True Lymph Node Involvement

Elizabeth M. Kurian et al.

HEAD & NECK PATHOLOGY (2020)

Add to Collection

Article Pathology

High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene

Hyun Lee et al.

HEAD & NECK PATHOLOGY (2020)

Add to Collection

Review Oncology

A compendium of mutational cancer driver genes

Francisco Martinez-Jimenez et al.

NATURE REVIEWS CANCER (2020)

Add to Collection

Article Pathology

Metastasizing Pleomorphic Adenoma Recurrent PLAG1/HMGA2 Rearrangements and Identification of a Novel HMGA2-TMTC2 Fusion

Jason K. Wasserman et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

Add to Collection

Letter Oncology

Trastuzumab-based therapy is effective for salivary duct carcinoma: Case report and review of the literature

Shihai Wu et al.

ORAL ONCOLOGY (2019)

Add to Collection

Article Pathology

NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors Is Intraductal Correct?

Alena Skalova et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

Add to Collection

Letter Pathology

Intraductal Papillary Mucinous Neoplasm of the Minor Salivary Gland With Associated Invasive Micropapillary Carcinoma

Shaodong Yang et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Nomenclature for cellular plasticity: are the terms as plastic as the cells themselves?

Jason C. Mills et al.

EMBO JOURNAL (2019)

Add to Collection

Article Oncology

Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling

Stacey M. Gargano et al.

CANCER MEDICINE (2019)

Add to Collection

Article Medical Laboratory Technology

Data Set for the Reporting of Carcinomas of the Major Salivary Glands Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting

Raja R. Seethala et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)

Add to Collection

Article Oncology

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma

Hideaki Takahashi et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Oncology

Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands

Carla Mosconi et al.

ORAL ONCOLOGY (2019)

Add to Collection

Review Pathology

Palatal Polymorphous Adenocarcinoma with High-Grade Transformation: A Case Report and Literature Review

Kentaro Kikuchi et al.

HEAD & NECK PATHOLOGY (2019)

Add to Collection

Review Pathology

Large cell neuroendocrine carcinoma of the submandibular gland: a case report and literature review

M. Mascitti et al.

PATHOLOGICA (2019)

Add to Collection

Article Pathology

NUT Carcinoma of the Salivary Glands Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas

Abbas Agaimy et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)

Add to Collection

Review Dentistry, Oral Surgery & Medicine

Current thinking about the management of recurrent pleomorphic adenoma of the parotid: a structured review

A. Kanatas et al.

BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

The PDGF/PDGFR pathway as a drug target

Natalia Papadopoulos et al.

MOLECULAR ASPECTS OF MEDICINE (2018)

Add to Collection

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting

Ziping Wu et al.

ONCOTARGETS AND THERAPY (2018)

Add to Collection

Review Oncology

NTRK fusion-positive cancers and TRK inhibitor therapy

Emiliano Cocco et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection

Article

Accurate diagnosis of mismatch repair deficiency in colorectal cancer using high-quality DNA samples from cultured stem cells

Tadayoshi Yamaura et al.

Oncotarget (2018)

Add to Collection

Article Pathology

Proceedings of the NASHNP Companion Meeting, March 18th, 2018, Vancouver, BC, Canada: Salivary Neuroendocrine Carcinoma-An Overview of a Rare Disease with an Emphasis on Determining Tumor Origin

Rebecca D. Chernock et al.

HEAD & NECK PATHOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA

Ilka Kristiansen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Add to Collection

Article Oncology

Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients

Kuninori Otsuka et al.

ANNALS OF SURGICAL ONCOLOGY (2016)

Add to Collection

Review Oncology

Genetic alterations in salivary gland cancers

Linda X. Yin et al.

CANCER (2016)

Add to Collection

Article Oncology

Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations

Kai Wang et al.

CLINICAL CANCER RESEARCH (2016)

Add to Collection

Article Otorhinolaryngology

Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients

Kevin Y. Zhan et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)

Add to Collection

Article Oncology

Outcomes and prognostic factors for major salivary gland carcinoma following postoperative radiotherapy

Ali Hosni et al.

ORAL ONCOLOGY (2016)

Add to Collection

Article Oncology

The landscape of gene fusions and somatic mutations in salivary gland neoplasms - Implications for diagnosis and therapy

Mattias K. Andersson et al.

ORAL ONCOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored

Stephen K. H. Li et al.

TRENDS IN MOLECULAR MEDICINE (2016)

Add to Collection

Article Pathology

Clinicopathologic and Immunophenotypic Characterization of 25 Cases of Acinic Cell Carcinoma with High-Grade Transformation

Lester D. Thompson et al.

HEAD & NECK PATHOLOGY (2016)

Add to Collection

Article Otorhinolaryngology

Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis

Boban M. Erovic et al.

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2015)

Add to Collection

Article Oncology

Histopathological grading of adenoid cystic carcinoma of the head and neck: Analysis of currently used grading systems and proposal for a simplified grading scheme

Stijn van Weert et al.

ORAL ONCOLOGY (2015)

Add to Collection

Article Medical Laboratory Technology

Lymphoepithelial-like carcinomas of the head and neck

Bruce M. Wenig

SEMINARS IN DIAGNOSTIC PATHOLOGY (2015)

Add to Collection

Article Surgery

Metastasising pleomorphic adenoma: Systematic review

James Knight et al.

INTERNATIONAL JOURNAL OF SURGERY (2015)

Add to Collection

Review Medicine, Research & Experimental

Etiology and Management of Recurrent Parotid Pleomorphic Adenoma

Robert L. Witt et al.

LARYNGOSCOPE (2015)

Add to Collection

Article Pathology

Primary Merkel Cell Carcinoma of the Submandibular Gland: When CK20 Status Complicates the Diagnosis

Davide Lombardi et al.

HEAD & NECK PATHOLOGY (2015)

Add to Collection

Article Oncology

Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications

Yoshitsugu Mitani et al.

CLINICAL CANCER RESEARCH (2014)

Add to Collection

Article Cell Biology

Prognostic features in mucoepidermoid carcinoma of major salivary glands with emphasis on tumour histologic grading

Nora Katabi et al.

HISTOPATHOLOGY (2014)

Add to Collection

Article Surgery

Surgical management of pleomorphic adenoma of parotid gland in elderly patients: Role of morphological features

Germano Guerra et al.

INTERNATIONAL JOURNAL OF SURGERY (2014)

Add to Collection

Article Pathology

Dedifferentiated Epithelial-Myoepithelial Carcinoma: Analysis of a Rare Entity Based on a Case Report and Literature Review

Aaron R. Baker et al.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2013)

Add to Collection

Review Pathology

''Dedifferentiation'' and High-Grade Transformation in Salivary Gland Carcinomas

Toshitaka Nagao

HEAD & NECK PATHOLOGY (2013)

Add to Collection

Article Pathology

Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma

Miki Ohe et al.

DIAGNOSTIC PATHOLOGY (2012)

Add to Collection

Article Oncology

Salivary gland carcinoma in Denmark 1990-2005: Outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA)

Kristine Bjorndal et al.

ORAL ONCOLOGY (2012)

Add to Collection

Review Pathology

Histologic Grading and Prognostic Biomarkers in Salivary Gland Carcinomas

Raja R. Seethala

ADVANCES IN ANATOMIC PATHOLOGY (2011)

Add to Collection

Article Pathology

Interobserver Reproducibility in the Diagnosis of Invasive Micropapillary Carcinoma of the Urinary Tract Among Urologic Pathologists

Ankur R. Sangoi et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)

Add to Collection

Article Pathology

An Update on Grading of Salivary Gland Carcinomas

Raja R. Seethala

HEAD & NECK PATHOLOGY (2009)

Add to Collection

Article Pathology

Primary invasive micropapillary carcinoma of the stomach

Masayuki Shimoda et al.

PATHOLOGY INTERNATIONAL (2008)

Add to Collection

Article Pathology

Adenoid cystic carcinoma with high-grade transformation: A report of 11 cases and a review of the literature

Raja R. Seethala et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)

Add to Collection

Article Biology

Dedifferentiation: A new approach in stem cell research

Sa Cai et al.

BIOSCIENCE (2007)

Add to Collection

Review Medicine, General & Internal

Androgen deprivation therapy for prostate cancer

N Sharifi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Add to Collection

Article Pathology

Invasive micropapillary salivary duct carcinoma - A distinct histologic variant with biologic significance

T Nagao et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)

Add to Collection

Article Pathology

Intraductal carcinoma of the oral cavity - A case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma

W Cheuk et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)

Add to Collection

Article Oncology

HER2 expression in salivary gland carcinomas: Dependence on histological subtype

B Glisson et al.

CLINICAL CANCER RESEARCH (2004)

Add to Collection

Article Pathology

Dedifferentiated malignant myoepithelioma of the parotid gland

I Ogawa et al.

PATHOLOGY INTERNATIONAL (2003)

Add to Collection

Article Pathology

Mucoepidermoid carcinoma - A clinicopathologic study of 80 patients with special reference to histological grading

MS Brandwein et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)

Add to Collection

Article Pathology

Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases

JE Lewis et al.

HUMAN PATHOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.